Abstract
Graft-versus-host disease (GVHD) holds a dual place in contemporary medicine. Clinically, it presents a serious problem in histocompatible bone marrow transplantation, and it is the principal limitation to histoincompatible bone marrow transplantation. Biologically, GVHD is a model for diseases of autoimmunity and immune dysregulation. After bone marrow transplantation, GVHD can present as either of two clinical syndromes: the acute disease, which is characterized by the cytolytic destruction of the recipient's skin, gastrointestinal tract, and liver; or chronic GVHD, in which there are scleroderma-like changes in the skin, gastrointestinal tract, and liver and the development of autoantibodies in the presence of . . .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
